Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy optimization studies torn between science and funding].

M Freund1

  • 1Abteilung Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin, Universität Rostock, Ernst-Heydemann-Str. 6, 18055 Rostock, Germany. mathias.freund@med.uni-rostock.de

Zeitschrift Fur Rheumatologie
|December 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional properties of human platelets derived in vitro from CD34<sup>+</sup> cells.

Scientific reports·2020
Same author

Microtubule plus-end tracking Adenopolyposis Coli negatively regulates proplatelet formation.

Scientific reports·2018
Same author

Lentiviral gene rescue of a Bernard-Soulier mouse model to study platelet glycoprotein Ibβ function.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Intractable Posterior Epistaxis due to a Spontaneous Low-Flow Carotid-Cavernous Sinus Fistula: A Case Report and a Review of the Literature.

Case reports in otolaryngology·2016
Same author

Characterization of the symbiont Rickettsia in the mirid bug Nesidiocoris tenuis (Reuter) (Heteroptera: Miridae).

Bulletin of entomological research·2014
Same author

[Not Available].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Clinical studies in Germany face significant funding and regulatory hurdles, hindering medical progress. Reforms are needed to streamline processes, ensure adequate funding, and support treatment-related clinical research for better patient outcomes.

Area of Science:

  • Medical research
  • Clinical trials
  • Health policy

Context:

  • Clinical studies are vital for advancing diagnostics and therapeutics.
  • Germany faces challenges with public funding for clinical research compared to other nations.
  • Existing regulations and bureaucratic processes impede the progress of clinical studies.

Purpose:

  • To highlight the critical need for reform in the regulatory and funding landscape of clinical studies in Germany.
  • To identify specific barriers including insurance costs, registration fees, and reimbursement issues.
  • To propose solutions for a more supportive environment for medical research.

Summary:

  • Clinical studies in Germany are underfunded and hampered by complex regulations and bureaucratic procedures.

Related Experiment Videos

  • Physicians and institutions incur significant costs for patient insurance and study registration.
  • Reimbursement for patient care in clinical studies is increasingly difficult due to outdated laws like Sozialgesetzbuch V.

    • Impact:

    • Implementing reforms can reduce financial burdens on researchers and institutions.
    • Streamlined regulations and dedicated funding can accelerate the development of new diagnostics and therapies.
    • Addressing these issues is crucial for enhancing patient safety and building a robust evidence base in medicine.